Tumor necrosis factor-alpha G-308 A polymorphism and risk of coronary heart disease and myocardial infarction: A case-control study and meta-analysis

Hongxia Chu, Jun Yang, Shaohua Mi, Soumitra Sudip Bhuyan, Jun Li, Lin Zhong, Shaorong Liu, Zhigang Tao, Jianping Li, Hongying Chen, Hongxia Chu, Jun Yang, Shaohua Mi, Soumitra Sudip Bhuyan, Jun Li, Lin Zhong, Shaorong Liu, Zhigang Tao, Jianping Li, Hongying Chen

Abstract

Objectives: The tumor necrosis factor-alpha (TNF-α) gene may play an important role in coronary heart disease (CHD) and myocardial infarction (MI) risk. Recently, controversial results regarding the association of the G-308 A (rs1800629)polymorphism of the TNF-α gene with CHD/MI have been reported. We herein examine a possible association between the G-308 A (rs1800629)polymorphism of the TNF-α gene and CHD/MI in a sample of the Chinese Han population.

Materials and methods: We determined the genotypes of TNF-α G-308 A (rs1800629) in 535 unrelated Chinese patients with CHD, 420 patients with MI, and 1020 coronary artery disease-free controls. Additionally, a meta-analysis of all previous studies on the TNF-α G-308 A polymorphism and the risk of CHD and MI was performed.

Results: AA genotypes in the G-308 A (rs1800629)polymorphism of the TNF-α gene did not occur more frequently in CHD/MI patients than in controls; odds ratios (95% confidence intervals) were 1.743 (0.325 to 1.423) for CHD and 1.731 (0.442 to 1.526) for MI, after adjusting for conventional risk factors. Further stratification for age, gender, and other cardiovascular risk factors did not alter the prior negative findings. Pooled meta-analysis of 23 studies also found no statistically significant associations between the TNF-α polymorphism and CHD/MI risk in the genetic additive, dominant, and recessive models. Subgroup analyses showed no association between the TNF-α polymorphism and CHD/MI in Asian and Caucasian populations.

Conclusion: Our study showed no association between the G-308 A (rs1800629) polymorphism of the TNF-α gene (presence of A allele) and CHD/MI in the Chinese Han population. There was no evidence of a difference in risk effects of rs1800629 between Caucasians and Asians.

Keywords: Coronary heart disease; meta-analysis; myocardial infarction; polymorphism; tumor necrosis factor-alpha.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Associations between G-308 A (rs1800629) polymorphism of the TNF-α gene and risk of CHD/MI were not observed

References

    1. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109:II2–10.
    1. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340:115–26.
    1. Zhao SP, Ye HJ, Zhou HN, Nie S, Li QZ. Gemfibrozil reduces release of tumor necrosis factor-α in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart. Clinica Chimica Acta. 2003;332:61–7.
    1. Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res. 2000;100:263–9.
    1. Ranjith N, Pegoraro RJ, Naidoo DP, Shanmugam R, Rom L. Genetic variants associated with insulin resistance and metabolic syndrome in young Asian Indians with myocardial infarction. Metab Syndr Relat Disord. 2008;6:209–14.
    1. Antonicelli R, Olivieri F, Cavallone L, Spazzafumo L, Bonafe M, Marchegiani F, et al. Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis. 2005;16:489–93.
    1. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegard J, Wiman B, et al. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis. 2006;187:408–14.
    1. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest. 1998;28:59–66.
    1. Ghazouani L, Khalifa SB, Abboud N, Addad F, Khalfallah AB, Brahim N, et al. -308G>A and -1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease. Clin Chem Lab Med. 2009;47:1247–51.
    1. Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Panagiotakos D, et al. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis. 2008;19:575–82.
    1. Elahi MM, Gilmour A, Matata BM, Mastana SS. A variant of position -308 of the Tumour necrosis factor alpha gene promoter and the risk of coronary heart disease. Heart Lung Circ. 2008;17:14–8.
    1. Araújo F, Pereira AC, Mota GF, Latorre Mdo R, Krieger JE, Mansur AJ. The influence of tumor necrosis factor –308 and C-reactive protein G1059C gene variants on serum concentration of C-reactive protein: Evidence for an age-dependent association. Clinica Chimica Acta. 2004;349:129–34.
    1. Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G, et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol. 2003;92:515–21.
    1. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM, Benoit MO, et al. Use of the bioMérieux VIDAS® troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clinica Chimica Acta. 2008;390:72–5.
    1. Shen GQ, Li L, Rao S, Abdullah KG, Ban JM, Lee BS, et al. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol. 2008;28:360–5.
    1. Allen RD. Polymorphism of the human TNF-alpha promoter--random variation or functional diversity? Mol Immunol. 1999;36:1017–27.
    1. Koch W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 2001;159:137–44.
    1. Szalai C, Fust G, Duba J, Kramer J, Romics L, Prohaszka Z, et al. Association of polymorphisms and allelic combinations in the tumour necrosis factor-alpha-complement MHC region with coronary artery disease. J Med Genet. 2002;39:46–51.
    1. Bernard V, Pillois X, Dubus I, Benchimol D, Labouyrie JP, Couffinhal T, et al. The -308 G/A tumor necrosis factor-alpha gene dimorphism: A risk factor for unstable angina. Clin Chem Lab Med. 2003;41:511–6.
    1. Tatenkulova SN, Mareev V, Zykov KA, Belenkov Iu N. The role of inflammatory factors in pathogenesis of ischemic heart disease. Kardiologiia. 2009;49:4–8.
    1. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, et al. Genotypes and haplotypes predisposing to myocardial infarction: A multilocus case-control study. Eur Heart J. 2004;25:459–67.
    1. Dedoussis GV, Panagiotakos DB, Vidra NV, Louizou E, Chrysohoou C, Germanos A, et al. Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: The CARDIO2000-GENE Study. Genet Med. 2005;7:411–6.
    1. Giacconi R, Cipriano C, Muti E, Costarelli L, Malavolta M, Caruso C, et al. Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients. Biogerontology. 2006;7:347–56.
    1. Sbarsi I, Falcone C, Boiocchi C, Campo I, Zorzetto M, De Silvestri A, et al. Inflammation and atherosclerosis: The role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol. 2007;20:145–54.
    1. Hou L, Huang J, Lu X, Wang L, Fan Z, Gu D. Polymorphisms of tumor necrosis factor alpha gene and coronary heart disease in a Chinese Han population: Interaction with cigarette smoking. Thromb Res. 2009;123:822–6.
    1. Liu Y, Jin W, Lu L, Chen QJ, Shen WF. Association between single nucleotide polymorphism in the promoter of tumor necrosis factor-α gene and coronary heart disease. J Diagn Concepts Pract. 2009;5:506–9.
    1. Li Y, Xu P, Chen H, Zhang PA, Huang CX. Association between tumor necrosis factor-α G-308 A gene polymorphism and coronary heart disease: A case-control study. Chin J Geriatr. 2003;9:568–9.
    1. Shun SY, Zeng XQ, Qi AM, Fan WH, Zhang JC. Association of tumor necrosis factor-alpha gene polymorphisms in the promoter region with chronic periodontitis and coronary heart disease. J Clin Stomatol. 2009;5:279–82.
    1. Chen ZQ, Ma JF, Qiu FY, Shi SL, Chen H. Plasma levels of TNF-α, but not TNF-α G-308 A gene polymorphism, is associated with coronary heart disease. Chin J Geriatr Cardiovasc Cerebrovasc Dis. 2001;06:156–8.
    1. Xiang PX, Li Y, Zhang PA, Chen H. Plasma TNF-α level and TNF-α gene polymorphism in patients with coronary heart disease: A case-control study. Lab Med. 2004;5:434–7.
    1. Banerjee I, Pandey U, Hasan OM, Parihar R, Tripathi V, Ganesh S. Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis. 2009;27:88–94.
    1. Tulyakova G, Nasibullin T, Salmanov A, Avzaletdinova D, Khusnutdinova E, Zakirova A. Association of the -308 (G/A) polymorphism of tumor necrosis factor-ã with myocardial infarction and sudden cardiac death. Balk J Med Genet. 2004;8:31–5.
    1. Wannamethee SG, Whincup PH, Shaper AG, Rumley A, Lennon L, Lowe GD. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost. 2009;7:1605–11.
    1. Sarwar N, Thompson AJ, Di Angelantonio E. Markers of inflammation and risk of coronary heart disease. Dis Markers. 2009;26:217–25.
    1. Kostner KM, Fahti RB, Case C, Hobson P, Tate J, Marwick TH. Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease. Clinica Chimica Acta. 2006;365:129–34.
    1. Keavney B, Danesh J, Parish S, Palmer A, Clark S, Youngman L, et al. Fibrinogen and coronary heart disease: test of causality by ‘Mendelian randomization’. Int J Epidemiol. 2006;35:935–43.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever